News
ELMD
16.39
+4.26%
0.67
Press Release: Electromed, Inc. Schedules its Third Quarter Fiscal 2024 Financial Results Conference Call for May 7, 2024 at 5:00 p.m. ET
Electromed, Inc. Schedules its Third Quarter Fiscal 2024 Financial Results Conference Call for May 7, 2024 at 5:00 p.m. ET. The company is a leader in innovative airway clearance technologies. Company management will host a conference call the same day to discuss the results.
Dow Jones · 12h ago
Weekly Report: what happened at ELMD last week (0415-0419)?
Weekly Report · 1d ago
Weekly Report: what happened at ELMD last week (0408-0412)?
Weekly Report · 04/15 11:04
Electromed, Inc. to Participate in the 2024 Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
Electromed, Inc. Is scheduled to attend the 2024 Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on April 17-18, 2024. Electromed’s management team will present at 10:30 a.m. Eastern Time on April 18. The company is a leader in innovative airway clearance technologies.
Barchart · 04/08 15:05
Weekly Report: what happened at ELMD last week (0401-0405)?
Weekly Report · 04/08 11:09
Weekly Report: what happened at ELMD last week (0325-0329)?
Weekly Report · 04/01 11:07
Weekly Report: what happened at ELMD last week (0318-0322)?
Weekly Report · 03/25 11:10
Weekly Report: what happened at ELMD last week (0311-0315)?
Weekly Report · 03/18 11:08
Weekly Report: what happened at ELMD last week (0304-0308)?
Weekly Report · 03/11 11:05
Weekly Report: what happened at ELMD last week (0226-0301)?
Weekly Report · 03/04 11:08
Weekly Report: what happened at ELMD last week (0219-0223)?
Weekly Report · 02/26 11:20
Electromed: Blowout Quarter, Beneficial 2024 Guidance, And Cheap
Electromed, Inc. Reported an impressive quarter and expects beneficial results for 2024. The company has a total market opportunity of 4.2 million Bronchiectasis patients. Electromed's stock repurchase program and recent price dynamics make it an attractive investment opportunity.
Seeking Alpha · 02/24 04:07
Weekly Report: what happened at ELMD last week (0212-0216)?
Weekly Report · 02/19 11:22
12 Health Care Stocks Moving In Wednesday's Intraday Session
Cogent Biosciences (NASDAQ:COGT) stock increased by 64.0% to $8.96 during Wednesday's regular session. The company's market cap stands at $771.2 million. Larimar Therapeutics shares increased by 45.53% and Electromed stock rose by 22.61%. Anitra stock declined by 71.3% during the session.
Benzinga · 02/14 17:31
BUZZ-U.S. STOCKS ON THE MOVE-CME Group, Robinhood Markets, Citigroup
Dow Jones Industrial Average was up 0.21% on Wednesday. Nvidia topped Alphabet's market value to become the third-most valuable U.S. Company. Uber Technologies Inc. Was the top percentage gainer on the S&P 500. The Nasdaq Composite was up 1%.
Reuters · 02/14 16:22
Analysts’ Top Healthcare Picks: Electromed (ELMD), Codexis (CDXS)
TipRanks · 02/14 13:50
Electromed Updates Investor Presentation for Transparency
TipRanks · 02/13 21:26
Recap: Electromed Q2 Earnings
Electromed reported its Q2 earnings of $0.19 on February 13, 2024. The company beat estimates by 90.0%. Electromed's revenue was up $1.96 million from the same period last year. Last quarter the company missed on its earnings by $.08.
Benzinga · 02/13 21:10
Electromed Q2 Gaap EPS $0.19 Beats $0.10 Estimate, Sales $13.69M Beat $13.30M Estimate
Electromed reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate by 90 percent. The company reported quarterly sales of $13.69 million which is a 16.71 percent increase over the same period last year. The shares of the company are up 2.9 percent.
Benzinga · 02/13 21:06
Press Release: Electromed, Inc. Announces Record -2-
Electromed, Inc. Has reported results for the three and six months ended December 31, 2017. The company's net revenues for the quarter were $16.7 million. The Company's total liabilities were $8.3 million. Electromed's shareholders' equity was $40.1 million for the period.
Dow Jones · 02/13 21:06
More
Webull provides a variety of real-time ELMD stock news. You can receive the latest news about Electromed through multiple platforms. This information may help you make smarter investment decisions.
About ELMD
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. The Company applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. Its SmartVest Connect wireless technology is a personalized HFCWO therapy management portal for patients with compromised pulmonary function. The SmartVest Connect app securely connects to the SmartVest System through Bluetooth technology. The Company also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.